ATE185792T1 - Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
ATE185792T1
ATE185792T1 AT96301517T AT96301517T ATE185792T1 AT E185792 T1 ATE185792 T1 AT E185792T1 AT 96301517 T AT96301517 T AT 96301517T AT 96301517 T AT96301517 T AT 96301517T AT E185792 T1 ATE185792 T1 AT E185792T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
containing same
derivatives
stilben derivatives
Prior art date
Application number
AT96301517T
Other languages
English (en)
Inventor
Toshihiro Hatanaka
Koji Ohsumi
Takashi Tsuji
Yukio Nihei
Ryusuke Nakagawa
Kazuo Ohishi
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE185792T1 publication Critical patent/ATE185792T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/33Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96301517T 1995-03-07 1996-03-06 Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen ATE185792T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4758195 1995-03-07

Publications (1)

Publication Number Publication Date
ATE185792T1 true ATE185792T1 (de) 1999-11-15

Family

ID=12779227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96301517T ATE185792T1 (de) 1995-03-07 1996-03-06 Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen

Country Status (12)

Country Link
US (1) US5674906A (de)
EP (1) EP0731085B1 (de)
KR (1) KR100352048B1 (de)
CN (1) CN1066713C (de)
AT (1) ATE185792T1 (de)
CA (1) CA2171275C (de)
DE (1) DE69604714T2 (de)
DK (1) DK0731085T3 (de)
ES (1) ES2137628T3 (de)
GR (1) GR3032311T3 (de)
PT (1) PT731085E (de)
TW (1) TW334418B (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100598474B1 (ko) * 1998-04-03 2006-07-11 아지노모토 가부시키가이샤 항종양제
US6624197B1 (en) 1998-05-08 2003-09-23 Calyx Therapeutics, Inc. Diphenylethylene compounds
US6331633B1 (en) 1998-05-08 2001-12-18 Calyx Therapeutics Inc. Heterocyclic analogs of diphenylethylene compounds
US7105552B2 (en) * 1998-05-08 2006-09-12 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6245814B1 (en) 1998-05-08 2001-06-12 Calyx Therapeutics, Inc. Diphenylethylene compounds
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
US6525093B1 (en) * 1999-11-08 2003-02-25 Calyx Therapeutics Inc. Compounds to treat diabetes and associated conditions
US20020002200A1 (en) * 2000-02-04 2002-01-03 Bishwagit Nag Novel diphenylethylene compounds
US20080108825A1 (en) * 1999-11-08 2008-05-08 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US7323496B2 (en) * 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
US20080103302A1 (en) * 2000-02-04 2008-05-01 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
JP2004505888A (ja) 2000-03-10 2004-02-26 ベイラー・ユニバーシテイ チューブリン結合リガンドおよび対応するプロドラッグ構造
EP1264821B1 (de) 2000-03-17 2008-05-14 Ajinomoto Co., Inc. Neues kristallines stilben-derivat und verfahren zu dessen herstellung
US6670344B2 (en) 2000-09-14 2003-12-30 Bristol-Myers Squibb Company Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts
US20050153939A1 (en) * 2003-09-10 2005-07-14 Bristol-Myers Squibb Company Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts
IL155509A0 (en) 2000-10-27 2003-11-23 Aventis Pharma Sa A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
US20020183266A1 (en) * 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
JP4779298B2 (ja) * 2001-06-25 2011-09-28 味の素株式会社 抗腫瘍剤
JPWO2003041740A1 (ja) * 2001-11-16 2005-03-03 味の素株式会社 腫瘍壊死剤
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
US20040224768A1 (en) * 2002-09-24 2004-11-11 Saied Hussaini Video game controller with integrated status indicators
US20040063502A1 (en) * 2002-09-24 2004-04-01 Intec, Inc. Power module
JPWO2004069243A1 (ja) 2003-02-04 2006-05-25 株式会社ヤクルト本社 乳癌耐性蛋白(bcrp)阻害剤
AU2004218412A1 (en) * 2003-02-28 2004-09-16 Oxigene, Inc. Compositions and methods with enhanced therapeutic activity
GB2403949A (en) 2003-07-18 2005-01-19 Sigma Tau Ind Farmaceuti Combretastatin derivatives
SG164378A1 (en) 2005-02-17 2010-09-29 Synta Pharmaceuticals Corp Compounds for the treatment of proliferative disorders
CN1301246C (zh) * 2005-04-20 2007-02-21 江苏省原子医学研究所 1-氰基-1-(3,5-二甲氧基苯基)-2-(4-r基苯基)乙烯及其制备方法
EP1746087A1 (de) 2005-07-21 2007-01-24 Universitaet Regensburg 3-Indolylmethylen-Derivate mit cytostatischer Wirkung
FR2895258B1 (fr) * 2005-12-22 2008-03-21 Aventis Pharma Sa Combinaison comprenant de la combretastatine et des agents anticancereux
CN101139358B (zh) 2006-09-07 2011-10-12 浙江大德药业集团有限公司 乙氧基康普立停及其前药的制备和用途
WO2008131368A2 (en) 2007-04-20 2008-10-30 Acucela Inc. Styrenyl derivative compounds for treating ophthalmic diseases and disorders
US20090264382A1 (en) 2007-11-21 2009-10-22 David Chaplin Methods for Treating Hematopoietic Neoplasms
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
US20130131018A1 (en) 2010-06-04 2013-05-23 Exonhit S.A. Substituted isoquinolines and their use as tubulin polymerization inhibitors
BR112012031917A2 (pt) 2010-06-18 2017-11-28 Sanofi Sa combinação antitumoral compreendendo ombrabulina, um derivado de taxano e um derivado de platina
EP2397135A1 (de) 2010-06-18 2011-12-21 Sanofi Antineoplastische Kombination, die Ombrabulin, ein Taxanderivat und ein Platinderivat umfasst
EP2481404A1 (de) 2010-11-15 2012-08-01 Sanofi Antineoplastische Kombination, die Ombrabulin, ein Taxanderivat und ein Platinderivat umfasst
EP2407161A1 (de) 2010-07-13 2012-01-18 Sanofi Antitumor-Kombination mit Ombrabulin und Bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
MX344772B (es) * 2011-01-28 2017-01-06 Univ Kentucky Res Found Analogos de estilbeno y metodos para tratar cancer.
CN102863388B (zh) 2011-07-05 2015-04-29 南京圣和药业股份有限公司 肿瘤靶向药物Combretastatin A4衍生物
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
WO2014089177A2 (en) 2012-12-04 2014-06-12 Massachusetts Institute Of Technology Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
AU2014228822A1 (en) 2013-03-15 2015-10-01 Memorial Sloan-Kettering Cancer Center HSP90-targeted cardiac imaging and therapy
EP3184095A1 (de) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Verabreichungseinheiten die ein polymorph 1 von 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide beinhalten
US9458086B1 (en) 2013-07-03 2016-10-04 University Of South Florida (A Florida Non-Profit Corporation) Compositions and methods for adipocyte modulation
US9394236B2 (en) 2014-02-03 2016-07-19 Quadriga Biosciences, Inc. β-substituted γ-amino acids and analogs as chemotherapeutic agents
WO2015117147A1 (en) * 2014-02-03 2015-08-06 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
US9487482B2 (en) * 2014-05-09 2016-11-08 Council Of Scientific And Industrial Research 3,4,5-trimethoxystyrylarylaminopropenones as potential anticancer agents
CA2994404C (en) 2015-08-03 2020-12-08 Quadriga Biosciences, Inc. Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof
US11419934B2 (en) 2015-08-18 2022-08-23 Oncotelic Therapeutics, Inc. Use of VDAS to enhance immunomodulating therapies against tumors
US10918627B2 (en) 2016-05-11 2021-02-16 Massachusetts Institute Of Technology Convergent and enantioselective total synthesis of Communesin analogs
US11932650B2 (en) 2017-05-11 2024-03-19 Massachusetts Institute Of Technology Potent agelastatin derivatives as modulators for cancer invasion and metastasis
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
CN112225673B (zh) * 2020-11-13 2022-08-02 义乌市华耀医药科技有限公司 氨基康普立停衍生物及其应用
US12030888B2 (en) 2021-02-24 2024-07-09 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL250327A (de) * 1959-04-08
GB9106177D0 (en) 1991-03-22 1991-05-08 Aston Molecules Ltd Substituted diphenylethylenes and analogues or derivatives thereof
WO1993023357A1 (en) 1992-05-21 1993-11-25 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
JP3180127B2 (ja) * 1993-03-10 2001-06-25 森永乳業株式会社 スチルベン誘導体とスチルベン同族体誘導体及びそれらの用途
TW325458B (en) * 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer

Also Published As

Publication number Publication date
TW334418B (en) 1998-06-21
CA2171275C (en) 2005-12-20
ES2137628T3 (es) 1999-12-16
CN1066713C (zh) 2001-06-06
KR100352048B1 (ko) 2003-05-12
US5674906A (en) 1997-10-07
DK0731085T3 (da) 2000-04-17
CA2171275A1 (en) 1996-09-08
PT731085E (pt) 2000-04-28
KR960034164A (ko) 1996-10-22
EP0731085A1 (de) 1996-09-11
CN1143629A (zh) 1997-02-26
DE69604714D1 (de) 1999-11-25
GR3032311T3 (en) 2000-04-27
DE69604714T2 (de) 2000-06-15
EP0731085B1 (de) 1999-10-20

Similar Documents

Publication Publication Date Title
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE174899T1 (de) Zytotoxische stilben-derivate und diese enthaltende pharmazeutische zusammensetzungen
DE69528005D1 (de) Prolineamid-Derivate
YU11997A (sh) Laktamski derivati i njihove farmaceutske kompozicije
TR200003478T2 (tr) Antikanser maddeleri olarak faydalı izotiyazol türevleri
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
ATE151775T1 (de) Trifluoromethylketon-tripeptidderivate
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
PT842923E (pt) Derivados do pirrolo e composicoes medicinais
BR9807330A (pt) Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
FI895139A0 (fi) Pyrrolidinderivat.
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
ES2168119T3 (es) Derivados de quinoxalina para el tratamiento de tinnitus.
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification